PHAT FY 2025 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$175M+216.9% YoY

Gross Profit

$153M87.1% margin

Operating Income

-$160M-91.4% margin

Net Income

-$221M-126.3% margin

EPS (Diluted)

$-3.03

Cash Flow

Operating Cash Flow

-$167M

Free Cash Flow

-$167M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$259M

Total Liabilities

$697M

Stockholders' Equity

-$438M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$175M	$55M	+216.9%
Gross Profit	$153M	$47M	+222.6%
Operating Income	-$160M	-$277M	+42.3%
Net Income	-$221M	-$334M	+33.8%